Ribosome biogenesis drives cell growth and proliferation, but mechanisms that modulate this process within specific lineages remain poorly understood. Here, we identify a Drosophila RNA polymerase I (Pol I) regulatory complex composed of Under-developed (Udd), TAF1B, and a TAF1C-like factor. Disruption of udd or TAF1B results in reduced ovarian germline stem cell (GSC) proliferation. Female GSCs display high levels of ribosomal RNA (rRNA) transcription, and Udd becomes enriched in GSCs relative to their differentiating daughters. Increasing Pol I transcription delays differentiation, whereas reducing rRNA production induces both morphological changes that accompany multicellular cyst formation and specific decreased expression of the bone morphogenetic protein (BMP) pathway component Mad. These findings demonstrate that modulating rRNA synthesis fosters changes in the cell fate, growth, and proliferation of female Drosophila GSCs and their daughters. L ineage-specific stem cell populations help to maintain tissues that experience high rates of cell turnover (1). Self-renewal and differentiation must be finely tuned to replace cells lost under normal physiological conditions and to rapidly compensate for acute cell loss. Although external cues from niches influence stem cellbased homeostasis (2-4), the intrinsic mechanisms that regulate differential growth and proliferation within stem cell lineages remain poorly understood.
L
ineage-specific stem cell populations help to maintain tissues that experience high rates of cell turnover (1). Self-renewal and differentiation must be finely tuned to replace cells lost under normal physiological conditions and to rapidly compensate for acute cell loss. Although external cues from niches influence stem cellbased homeostasis (2) (3) (4) , the intrinsic mechanisms that regulate differential growth and proliferation within stem cell lineages remain poorly understood.
We isolated the Drosophila recessive mutation under-developed 1 and udd null mutant GSCs became less proliferative and were eventually lost from the cap cell niche (Fig. 1) .
Costaining with Modulo (Mod) (7) revealed that Udd protein exhibits ubiquitous expression and localizes to the nucleoli of nondividing cells (n > 100 cells) ( Fig. 2A and fig. S3 ). Tandem purification and mass spectrometry ( fig. S4 ), followed by coimmunoprecipitation (Fig. 2B and  fig. S4 ), revealed that Udd associates with two proteins, CG6241 and CG10496. CG6241 shares homology with human TATA box-binding proteinassociated factor RNA polymerase I subunit B (TAF1B) and yeast Rrn7 (8, 9) (fig. S5 ), whereas CG10496 resembles human TAF1C on the basis of sequence and secondary-structure analyses ( fig. S6 ). CG6241 and CG10496 will hereafter be referred to as TAF1B and TAF1C-like, respectively. Human TAF1B and TAF1C are components of the selectivity factor 1 (SL1) complex, which promotes RNA polymerase I (Pol I) transcription (10) (11) (12) . Drosophila TAF1B and the TAF1C-like factor localized to nucleoli (Fig. 2, C fig. S7 ). Northern blot analysis (14) showed that udd mutants displayed a reduction in both pre-rRNA and processed rRNA inter- mediates (Fig. 2F and fig. S9 ). Chromatin immunoprecipitation (ChIP) experiments revealed that Udd associates with the rDNA promoter ( Fig. 2G  and fig. S9 ). Together these data indicate that the Udd, TAF1B, and TAF1C-like complex likely functions in a manner analogous to that of the human SL1 complex to promote Pol I transcription ( fig. S7 ). As expected, disruption of Pol I transcription impeded ribosome production based on the nuclear accumulation of green fluorescent protein (GFP)-tagged RpS2 in udd 1 /udd null mutant cells ( fig. S9 ).
GSCs exhibited higher levels of rRNA synthesis and nucleolar Udd relative to their immediate progeny (Fig. 3A and fig. S10 ). These differences correlated with the expression of Bam, a key differentiation factor (15) (16) (17) (Fig.  3B and fig. S10 ). Wicked, a component of the rRNA processing U3 small nucleolar ribonucleoprotein (snoRNP) complex, becomes enriched in cytoplasmic particles that asymmetrically segregate to presumptive GSCs during mitosis (18) . To determine whether Udd also becomes asymmetrically enriched within GSCs, we performed immunofluorescence analysis of endogenous Udd and time-lapse microscopy using a rescuing GFPtagged Udd genomic transgene (Fig. 3C , figs. S11 and S12, and movies S1 to S8). Live imaging showed discrete Udd-GFP localization during prophase. Udd-GFP dispersed during metaphase and anaphase, but a small amount of endogenous Udd remained associated with chromosomes through most of mitosis ( fig. S11 ). At the end of telophase, GFP-tagged and endogenous Udd recoalesce within the nucleoli of newly formed GSCs more quickly and at higher levels relative to their sibling cells oriented away from the cap cells ( Fig. 3C and fig. S11 ). By contrast, Udd appeared evenly distributed in multicellular cyst nucleoli immediately after mitosis ( fig. S12 ).
Udd and rRNA synthesis did not decrease in bam ∆86 mutant germ cells (Fig. 3D and fig. S10 ), suggesting that persistently low levels of Pol I transcription during early cyst differentiation correlate with the developmental state of these cells and not with their position relative to the niche. To further explore this idea, we overexpressed an inducible bam transgene in a bam ∆86 mutant background. Following bam expression, the germ cells differentiated into multicellular cysts, and both nucleolar Udd and nascent rRNA production levels decreased (Fig. 3E and fig. S10 ).
To examine the functional significance of reduced rRNA transcription in early differentiating cells, we crossed the udd 1 mutation into a bam ∆86 mutant background. Although bam ∆86 mutant cells remained as single cells with round fusomes (Fig. 4A and fig. S13 ), udd 1 bam ∆86 double-mutant germaria (94.7%; n = 94) contained many four-and eight-cell cysts with branched fusomes and ring canals (Fig. 4B and fig. S13 ). Mature 16-cell cysts were not observed. RNAi knockdown of TAF1B in a bam RNAi background also resulted in multicellular cyst formation (fig. S13). Consistent with the idea that reduced translation promotes morphological changes that accompany early germline differentiation, knockdown of an rRNA processing factor, ribosomal proteins, and a translation initiation factor in a bam loss-offunction background also resulted in multicellular cyst formation (fig. S13) . udd 1 bam ∆86 doublemutant germ cells maintain nucleolar fibrillarin and fail to down-regulate sex-lethal and up-regulate A2bp1 despite forming multicellular cysts (figs. S14 and S15).
The udd bam double-mutant phenotype suggested that attenuation of Pol I activity promotes some of the early steps of germ cell differentiation. We speculated that increasing rRNA transcription in stem cell daughters exiting the niche might delay their ability to initiate cyst formation. Overexpression of TIF-IA, a conserved factor that bridges divergent Pol I regulatory factors with the Pol I transcriptional complex, results in greater rRNA transcription (19) . Although we could not drive robust TIF-IA expression ( fig. S16 ), low levels of TIF-IA overexpression 299 REPORTS resulted in a modest but significant increase in the number of single germ cells with round fusomes within germaria and the percentage of germaria containing over five single undifferentiated cells (Fig. 4, C to E) . These cells continued to express Dad-LacZ, a hallmark of bone morphogenetic protein (BMP) signal transduction and GSC identity (20) (Fig. 4, F to H) . We compared the levels of two downstream components of the 
histone H2B, indicating that modulation of rRNA transcription affects the expression of specific proteins that regulate cell-fate decisions within the GSC lineage (Fig. 4I and fig.  S16 ). Down-regulation of Mad in response to reduced rRNA transcription likely acts in concert with other mechanisms that extinguish BMP signaling in GSC daughters displaced away from the stem cell niche (22, 23) .
Besides TIF-IA and dMyc (19, 24) , few regulators of Drosophila Pol I have been characterized. The identification of a Drosophila SL1-like complex provides insights into the mechanisms that regulate rRNA transcription in a developmental context ( fig. S16D) . Seminal work has shown that specific cellular structures asymmetrically segregate during stem cell divisions in Drosophila and mice (18, (25) (26) (27) . Results presented here indicate that rRNA transcriptional machinery also partitions unevenly during certain cell divisions. These data reveal that distinct levels of ribosome biogenesis, once considered a generally constitutive process, modulate the expression of specific proteins that direct cell fate decisions, growth, and proliferation within an in vivo stem cell lineage more rapidly or to a greater extent than others. Notably, the direction of asymmetric enrichment of ribosome biogenesis factors may be reversed in other lineages, especially in those stem cells destined to enter a quiescent state. These findings may have important implications for human ribosome-related diseases (28, 29) .
Lenalidomide is a drug with clinical efficacy in multiple myeloma and other B cell neoplasms, but its mechanism of action is unknown. Using quantitative proteomics, we found that lenalidomide causes selective ubiquitination and degradation of two lymphoid transcription factors, IKZF1 and IKZF3, by the CRBN-CRL4 ubiquitin ligase. IKZF1 and IKZF3 are essential transcription factors in multiple myeloma. A single amino acid substitution of IKZF3 conferred resistance to lenalidomide-induced degradation and rescued lenalidomide-induced inhibition of cell growth. Similarly, we found that lenalidomide-induced interleukin-2 production in T cells is due to depletion of IKZF1 and IKZF3. These findings reveal a previously unknown mechanism of action for a therapeutic agent: alteration of the activity of an E3 ubiquitin ligase, leading to selective degradation of specific targets. L enalidomide is a highly effective drug for the treatment of multiple myeloma (1) and has activity in other B cell lymphomas. In addition, lenalidomide and its analogs thalidomide and pomalidomide have multiple additional biological effects, including teratogenicity, stimulation of interleukin-2 (IL-2) production by T cells (2) , and inhibition of tumor necrosis factor production by monocytes (3), but the molecular basis of these pleiotropic activities is unknown.
Using an immobilized derivative of lenalidomide in combination with SILAC (stable isotope labeling of amino acids in cell culture)-based quantitative mass spectrometry (MS), we found that lenalidomide binds DDB1 and CRBN that, together with CUL4 and ROC1, form an E3 ubiquitin ligase (CRBN-CRL4) ( fig. S1 ). The same target has recently been reported to bind thalidomide and has been implicated in the teratogenetic effects of thalidomide (4). The finding that CRBN-DDB1 binds both lenalidomide and thalidomide in independent proteomic studies provides powerful evidence that this ubiquitin ligase complex is a major direct proteinbinding partner for this class of molecules.
We hypothesized that the pleiotropic effects of lenalidomide might be caused by altered ubiquitination of target proteins. Specificity of the CRL4 ubiquitin ligase is mediated by an interchangeable substrate receptor, but no targets have been identified for CRBN, a putative substrate receptor (4-6). To characterize lenalidomideinduced modulation of CRBN-CRL4 ubiquitin ligase activity, we used SILAC-based quantitative MS studies to characterize changes in the ubiquitinome and proteome in the MM1S multiple myeloma cell line. Ubiquitination profiling was completed through the enrichment of formerly ubiquitinated peptides with an antibody to K-e-GG (Fig. 1A) (7, 8) . Two proteins, Ikaros (IKZF1) and Aiolos (IKZF3), scored at the top of the lists of proteins regulated by lenalidomide at both the protein and ubiquitin-site level (Fig. 1, B and C) . Lenalidomide decreased the abundance of IKZF3 (log 2 ratio -2.09) and IKZF1 (log 2 ratio -1.54). Whereas increased ubiquitination would be expected to be associated with decreased protein abundance,
